GlassScriptPhysician profile
Jessica Mosher
NPI 1063471050
$163.82
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.83 · 2020: $23.69 · 2021: $52.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $90.33 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $24.98 | 2021 | |
| Dermira, INC. | $19.88 | 2019 | |
| Amgen INC. | $16.18 | 2019 | |
| Genzyme Corporation | $12.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$21,375.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mosher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.